Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms

Clinical Pharmacology and Therapeutics

Volumn 62, Issue 1, 1997, Pages 60-73

  Otterness, Diane ^b   Szumlanski, Carol ^b   Lennard, Lynne ^b   Klemetsdal, Bjørg ^b   Aarbakke, Jarle ^b   Park Hah, Jeong Ok ^b   Iven, Heiko ^b   Schmiegelow, Kjeld ^b   Branum, Earl ^b   O'Brien, John ^b   Weinshilboum, Richard ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

THIOPURINE METHYLTRANSFERASE;

ADULT; ALLELE; ARTICLE; CHILD; ENZYME ACTIVITY; ETHNIC GROUP; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PHARMACOGENETICS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; DNA PRIMERS; ERYTHROCYTES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; KOREA; METHYLTRANSFERASES; NORWAY; POLYMORPHISM, GENETIC; UNITED STATES;

EID: 12644291917     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(97)90152-1     Document Type: Article

References (39)

1. Remy CN. Metabolism of thiopyrimidines and thiopurines: S-methylation with S-adenosylmethionine transmethylase and catabolism in mammalian tissue. J Biol Chem 1963;238:1078-84.
2. Woodson LC, Weinshilboum RM. Human kidney thiopurine methyltransferase: purification and biochemical properties. Biochem Pharmacol 1983;32: 819-26.
3. Deininger M, Szumlanski CL, Otterness DM, Van Loon J, Ferber W, Weinshilboum RM. Purine substrates for human thiopurine methyltransferase. Biochem Pharmacol 1994;48:2135-8.
4. Paterson ARP, Tidd DM. 6-Thiopurines. In: Sarotelli AC, Johns DG, editors. Antineoplastic and immunosuppressive agents II. New York: Springer Verlag, 1975:384-403.
5. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980;32:651-62.
6. Woodson LC, Dunnette JH, Weinshilboum RM. Pharmacogenetics of human thiopurine methyltransferase: kidney-erythrocyte correlation and immunotitration studies. J Pharmacol Exp Ther 1982;222:174-81.
7. Weinshilboum R. Methyltransferase pharmacogenetics. Pharmacol Ther 1989;43:77-90.
8. Weinshilboum RM. Methylation pharmacogenetics: thiopurine methyltransferase as a model system. Xenobiotica 1992;22:1055-71.
9. Krynetski EY, Tai HL, Yates CR, Fessing MY, Loennechen T, Schuetz JD, et al. Genetic polymorphism of thiopurine methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics 1996;6: 279-90.
10. Lennard L, Van Loon JA, Lilleyman JS, Weinshilboum RM. Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clin Pharmacol Ther 1987;41:18-25.
11. Lennard L, Van Loon JA, Weinshilboum RM. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther 1989;46:149-54.
12. Lennard L, Lilleyman JS, Van Loon J, Weinshilboum RM. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet 1990;336:225-9.
13. Lennard L, Gibson BES, Nicole T, Lilleyman JS. Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukemia. Arch Dis Child 1993; 69:577-9.
14. Evans WE, Horner M, Chu YQ, Kalwinsky D, Roberts WM. Altered mercaptopurine metabolism, toxic effects and dosage requirement in a thiopurine methyltransferase-deflcient child with acute lymphoblastic leukemia. J Pediatr 1991;119:985-9.
15. Schütz E, Gummert J, Mohr F, Oellerich M. Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient [letter]. Lancet 1993;341:436.
16. Lilleyman JS, Lennard L. Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia. Lancet 1994;343:1188-90.
17. Van Loon JA, Weinshilboum RM. Thiopurine methyltransferase biochemical genetics: human lymphocyte activity. Biochem Genet 1982;20:637-58.
18. Szumlanski CL, Honchel R, Scott MC, Weinshilboum RM. Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, livererythrocyte correlation and presence of isozymes. Pharmacogenetics 1992;2:148-59.
19. McLeod HL, Relling MV, Lin Q, Pui CH, Evans WE. Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia. Blood 1995;7:1897-902.
20. Mayo Foundation Laboratory Medicine Bulletin. Thiopurine methyltransferase measurement. Dec 6, 1991;14:1.
21. McLeod HL, Lin JS, Scott EP, Pui CH, Evans WE. Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther 1994;55:15-20.
22. Klemetsdal B, Tollefsen E, Loennechen T, Johnsen K, Utsi E, Gisholt K, et al. Interethnic difference in thiopurine methyltransferase activity. Clin Pharmacol Ther 1992;51:24-31.
23. Park-Hah JO, Klemetsdal B, Lysaa R, Choi KH, Aarbakke J. Thiopurine methyltransferase activity in a Korean population sample of children. Clin Pharmacol Ther 1996;60:68-74.
24. Jang IJ, Shin SG, Lee KH, Yim DS, Lee MS, Koo HH, et al. Erythrocyte thiopurine methyltransferase activity in a Korean population. Br J Pharmacol 1996; 42:638-41.
25. Honchel R, Aksoy I, Szumlanski C, Wood TC, Otterness DM, Wieben ED, et al. Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA. Mol Pharmacol 1993;43:878-87.
26. Lee D, Szumlanski C, Houtman J, Honchel R, Rojas K, Overhauser J, et al. Thiopurine methyltransferase pharmacogenetics: cloning of human liver cDNA and presence of a processed pseudogene on human chromosome 18q21.1. Drug Metab Dispos 1995;23:398-405.
27. Szumlanski C, Otterness D, Her C, Lee D, Brandriff B, Kelsell D, et al. Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism. DNA Cell Biol 1996;15:17-30.
28. Krynetski EY, Schuetz JD, Galpin AJ, Pui CH, Relling MV, Evans WE. A single point mutation leading to loss of catalytic activity in human thiopurine methyltransferase. Proc Natl Acad Sci USA 1995;92:949-53.
29. Tai HL, Krynetski EY, Yates CR, Loennechen T, Fessing MY, Krynetskaia NF, et al. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet 1996;58:694-702.
30. Otterness DM, Szumlanski CL, Weinshilboum RW. Human thiopurine methyltransferase pharmacogenetics: identification of a novel variant allele [abstract]. J Invest Med 1996;44:248A.
31. Mount SM. A catalogue of splice junction sequences. Nucleic Acids Res 1982; 10:459-72.
32. Weinshilboum RM, Raymond FA, Pazmiño PA. Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta 1978;85:323-33.
33. Klemetsdal B, Straume B, Lysaa R, Giverhaug T, Aarbakke J. Erythrocyte fraction affects red blood cell thiopurine methyltransferase activity. Eur J Clin Pharmacol 1995;48:495-9.
34. Saiki RK, Sharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, et al. Enzymatic amplification of betaglobin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230: 1350-4.
35. Saiki RK, Gelfand DH, Stoffel S, Sharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-91.
36. Chadwick RB, Conrad MP, McGinnis MD, Johnston-Dow L, Spurgeon SL, Kronick MN. Heterozygote and mutation detection by direct automated fluorescent DNA sequencing using a mutant Taq DNA polymerase. Biotechniques 1996;20:676-83.
37. Savov A, Angelicheva D, Balassopoulou A, Jordanova A, Noussia-Arvanitakis S, Kaladjieva L. Double mutant alleles: are they rare? Hum Mol Genet 1995;4:1169-71.
38. Kalow W. Pharmacoanthropology and the genetics of drug metabolism. In: Kalow W, editor. Pharmacogenetics of drug metabolism; chapter 35. New York: Pergamon Press, 1992:865-77.
39. Vuchetich JP, Weinshilboum RM, Price RA. Segregation analysis of human red blood cell (RBC) thiopurine methyltransferase (TPMT) activity. Genet Epidemiol 1995;12:1-11.